NO983054L - Virale rekombinante pseudopartikler og anvendelse som vaksiner og som anti-tumormiddel - Google Patents

Virale rekombinante pseudopartikler og anvendelse som vaksiner og som anti-tumormiddel

Info

Publication number
NO983054L
NO983054L NO983054A NO983054A NO983054L NO 983054 L NO983054 L NO 983054L NO 983054 A NO983054 A NO 983054A NO 983054 A NO983054 A NO 983054A NO 983054 L NO983054 L NO 983054L
Authority
NO
Norway
Prior art keywords
vaccines
viral
pseudoparticles
tumor agents
viral recombinant
Prior art date
Application number
NO983054A
Other languages
English (en)
Other versions
NO324205B1 (no
NO983054D0 (no
Inventor
Ignacio Casal
Christine Sedlik
Javier Sarraseca
Claude Leclerc
Richard Lo Man
Paloma Rueda
Original Assignee
Pasteur Institut
Immunologia Y Genetica Apl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Immunologia Y Genetica Apl Sa filed Critical Pasteur Institut
Publication of NO983054D0 publication Critical patent/NO983054D0/no
Publication of NO983054L publication Critical patent/NO983054L/no
Publication of NO324205B1 publication Critical patent/NO324205B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/802—Virus-based particle
    • Y10S977/803—Containing biological material in its interior
    • Y10S977/804—Containing nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19983054A 1996-01-02 1998-07-01 Rekombinante virale pseudopartikler, sammensetning, anvendelse og fremgangsmate for in vitro stimulering av T-cytotoksiske responser. NO324205B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96400009A EP0783038B1 (fr) 1996-01-02 1996-01-02 Pseudo-particules virales recombinantes et applications vaccinales et antitumorales
PCT/FR1996/001337 WO1997024443A1 (fr) 1996-01-02 1996-08-30 Pseudo-particules virales recombinantes et applications vaccinales et antitumorales

Publications (3)

Publication Number Publication Date
NO983054D0 NO983054D0 (no) 1998-07-01
NO983054L true NO983054L (no) 1998-08-14
NO324205B1 NO324205B1 (no) 2007-09-10

Family

ID=8225214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983054A NO324205B1 (no) 1996-01-02 1998-07-01 Rekombinante virale pseudopartikler, sammensetning, anvendelse og fremgangsmate for in vitro stimulering av T-cytotoksiske responser.

Country Status (15)

Country Link
US (1) US6458362B1 (no)
EP (2) EP0783038B1 (no)
JP (1) JP2000502900A (no)
AT (1) ATE317901T1 (no)
AU (1) AU731706B2 (no)
BR (1) BR9612422A (no)
CA (1) CA2241280A1 (no)
DE (1) DE69635825T2 (no)
DK (1) DK0871738T3 (no)
ES (2) ES2282998T3 (no)
IL (1) IL167886A (no)
NO (1) NO324205B1 (no)
NZ (1) NZ316970A (no)
PT (1) PT871738E (no)
WO (1) WO1997024443A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124523T2 (de) * 2001-07-10 2007-09-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
KR20050110709A (ko) * 2003-04-07 2005-11-23 코닌클리즈케 필립스 일렉트로닉스 엔.브이. 디스플레이 장치
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
JP5710254B2 (ja) * 2007-09-14 2015-04-30 アンスティテュ・パストゥールＩｎｓｔｉｔｕｔ Ｐａｓｔｅｕｒ 外来エピトープを含む組換え偽ウイルスの発現および分泌を可能とするポリヌクレオチド、それらの製造および使用
WO2009151697A2 (en) * 2008-03-14 2009-12-17 The Government Of United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and processes relating to human bocavirus
CN116640189B (zh) * 2023-04-13 2024-08-27 北京烁谷生物科技有限公司 一种病原微生物快速检测试剂盒及其应用
CN117866053B (zh) * 2024-01-10 2024-07-02 武汉珈创生物技术股份有限公司 同时检测多种猪细小病毒的多克隆抗体及其制备和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8902301A (nl) * 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

Also Published As

Publication number Publication date
ES2257753T3 (es) 2006-08-01
NO324205B1 (no) 2007-09-10
DE69635825D1 (de) 2006-04-20
EP0871738A1 (fr) 1998-10-21
BR9612422A (pt) 1999-12-28
DE69635825T2 (de) 2006-10-19
PT871738E (pt) 2006-07-31
EP0783038B1 (fr) 2007-04-04
DK0871738T3 (da) 2006-06-19
WO1997024443A1 (fr) 1997-07-10
CA2241280A1 (fr) 1997-07-10
AU6933296A (en) 1997-07-28
ATE317901T1 (de) 2006-03-15
IL167886A (en) 2011-02-28
ES2282998T3 (es) 2007-10-16
JP2000502900A (ja) 2000-03-14
EP0783038A1 (fr) 1997-07-09
AU731706B2 (en) 2001-04-05
NO983054D0 (no) 1998-07-01
NZ316970A (en) 1999-03-29
US6458362B1 (en) 2002-10-01
EP0871738B1 (fr) 2006-02-15

Similar Documents

Publication Publication Date Title
ATE188612T1 (de) Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend
PT992580E (pt) Epitopos para celulas t humanas imunodominantes do virus da hepatite c
ATE64601T1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
LU92237I2 (fr) Pegloticase et toute forme thérapeutique équivalente protégée par le brevet de base
EP1009756A4 (en) RECOMBINANT HUMAN-IgA-J CHAIN DIMER
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
ATE170220T1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
DK1668031T3 (da) Homogene præparater af IL-29
DE69131662D1 (de) Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine
NO983054D0 (no) Virale rekombinante pseudopartikler og anvendelse som vaksiner og som anti-tumormiddel
EP0422125A4 (en) Platelet blocking peptides
ATE265535T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
NO921829L (no) Nytt polypeptid, samt anti-hiv-medikament fremstilt derav
DE69227898D1 (de) Rekombinante hybride porinepitope
ATE135407T1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
DK107389A (da) Modificerede proteiner
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
ATE312923T1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
IT1270941B (it) Peptidi di hcv e loro usi.
KR950028783A (ko) C형 간염 바이러스에 대한 인체면역 조절기능을 가진 펩타이드

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees